Susanne Stuffers
Chief Executive Officer chez P53 Invest AS
Fortune : 12 587 $ au 31/03/2024
Profil
Susanne Stuffers is currently the Chief Executive Officer & Managing Partner and CEO & Founding Partner at P53 Invest AS and P53 respectively.
She is also the Vice Chairman at Arxx Therapeutics AS.
Previously, she worked as a Director at Nykode Therapeutics ASA, Independent Director at Gentian Diagnostics ASA, and Director at EXACT Therapeutics AS.
She was also a Lead Analyst at Arctic Securities AS from 2015 to 2018.
Dr. Stuffers holds a doctorate degree from Erasmus University Rotterdam, which she received in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENTIAN DIAGNOSTICS ASA
0,02% | 31/12/2022 | 3 500 ( 0,02% ) | 12 587 $ | 31/03/2024 |
Postes actifs de Susanne Stuffers
| Sociétés | Poste | Début |
|---|---|---|
P53 Invest AS
 P53 Invest AS Financial ConglomeratesFinance Part of T.D. Veen AS, P53 Invest AS provides investment services for the healthcare industry. The private company is based in Oslo, Norway. Susanne Stuffers has been the CEO of the Norwegian company since 2018. | Chief Executive Officer | 01/11/2018 |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Director/Board Member | - |
Anciens postes connus de Susanne Stuffers
| Sociétés | Poste | Fin |
|---|---|---|
Arctic Securities AS
 Arctic Securities AS Investment Banks/BrokersFinance Arctic Securities AS is a Norwegian company that provides brokerage services. The private company is based in Oslo, Norway. and has subsidiaries in Norway, Sweden and Germany. The company was founded in 2007 by Jon G. Pedersen, Mads Henrik Syversen. Mads Henrik Syversen has been the CEO since 2007. | Analyst-Equity | 01/10/2018 |
| EXACT THERAPEUTICS | Director/Board Member | - |
| GENTIAN DIAGNOSTICS | Director/Board Member | - |
| NYKODE THERAPEUTICS | Director/Board Member | - |
Formation de Susanne Stuffers
| Erasmus University Rotterdam | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NYKODE THERAPEUTICS | Health Technology |
| GENTIAN DIAGNOSTICS | Health Technology |
| EXACT THERAPEUTICS | Health Technology |
| Entreprise privées | 3 |
|---|---|
Arctic Securities AS
Arctic Securities AS Investment Banks/BrokersFinance Arctic Securities AS is a Norwegian company that provides brokerage services. The private company is based in Oslo, Norway. and has subsidiaries in Norway, Sweden and Germany. The company was founded in 2007 by Jon G. Pedersen, Mads Henrik Syversen. Mads Henrik Syversen has been the CEO since 2007. | Finance |
P53 Invest AS
P53 Invest AS Financial ConglomeratesFinance Part of T.D. Veen AS, P53 Invest AS provides investment services for the healthcare industry. The private company is based in Oslo, Norway. Susanne Stuffers has been the CEO of the Norwegian company since 2018. | Finance |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Health Technology |
